Kite Pharma Inc (KITE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | KITE | AMGN | VRTX | BMY | REGN |
| Company | Kite Pharma Inc | Amgen Inc | Vertex Pharmaceutic | Bristol-Myers Squibb Company | Regeneron Pharmaceuticals |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NYSE | NASDAQ |
| Open | 179.99 | 313.39 | 401.50 | 43.90 | 926.94 |
| High | 179.99 | 322.60 | 405.67 | 44.33 | 947.08 |
| Low | 179.99 | 310.65 | 397.59 | 43.69 | 926.94 |
| Last | 179.99 | 313.96 | 400.24 | 43.93 | 943.55 |
| Change | +0.20 | +35.57 | +0.08 | +0.23 | +5.94 |
| % Change | +0.11% | +12.78% | +0.02% | +0.53% | +0.63% |
| Volume | 100 | 5,737,719 | 365,402 | 4,515,082 | 151,012 |
| 20-Day Average Volume | 2,576,370 | 2,444,967 | 986,517 | 14,077,693 | 498,538 |
| Previous Close | 179.79 | 278.39 | 400.16 | 43.70 | 937.61 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 179.18 | 272.40 | 398.41 | 47.46 | 909.13 |
| 20-Day Raw Stochastic | 100.00% | 85.98% | 60.85% | 6.85% | 90.39% |
| 20-Day Relative Strength | 86.68% | 72.96% | 46.83% | 28.73% | 55.40% |
| Weighted Alpha | +211.40 | +35.25 | +14.21 | -36.84 | +24.03 |
| Today's Opinion | N/A | 24% Buy | 8% Buy | 100% Sell | 48% Buy |
| Previous Opinion | N/A | 16% Sell | 8% Buy | 88% Sell | 48% Buy |
| Last Month's Opinion | N/A | 24% Sell | 24% Buy | 8% Sell | 56% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.19% since 09/26/17 | +16.28% since 04/26/24 | +0.81% since 04/26/24 | -2.11% since 04/26/24 | +6.67% since 04/26/24 |
| Low | 179.55 on 10/02/17 | 268.99 on 04/29/24 | 391.70 on 04/30/24 | 43.33 on 05/02/24 | 883.20 on 04/29/24 |
| High | 179.99 on 10/03/17 | 322.60 on 05/03/24 | 406.95 on 05/01/24 | 45.38 on 04/29/24 | 946.81 on 05/03/24 |
| 1-Month | |||||
| %Chg | +1.09% since 09/01/17 | +14.39% since 04/03/24 | -1.98% since 04/03/24 | -15.86% since 04/03/24 | -0.93% since 04/03/24 |
| Low | 177.65 on 09/05/17 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 43.33 on 05/02/24 | 875.22 on 04/26/24 |
| High | 179.99 on 10/03/17 | 322.60 on 05/03/24 | 412.64 on 04/04/24 | 52.08 on 04/04/24 | 962.20 on 04/04/24 |
| 3-Month | |||||
| %Chg | +72.35% since 07/03/17 | -2.87% since 02/02/24 | -5.64% since 02/02/24 | -9.86% since 02/02/24 | -0.33% since 02/02/24 |
| Low | 100.09 on 07/10/17 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 43.33 on 05/02/24 | 875.22 on 04/26/24 |
| High | 179.99 on 10/03/17 | 329.72 on 02/05/24 | 437.00 on 02/27/24 | 55.03 on 03/13/24 | 998.33 on 02/28/24 |
| 6-Month | |||||
| %Chg | +130.11% since 04/03/17 | +16.33% since 11/03/23 | +6.52% since 11/03/23 | -16.88% since 11/03/23 | +15.33% since 11/03/23 |
| Low | 66.75 on 05/09/17 | 260.52 on 11/21/23 | 341.90 on 11/16/23 | 43.33 on 05/02/24 | 783.57 on 11/10/23 |
| High | 179.99 on 10/03/17 | 329.72 on 02/05/24 | 448.40 on 01/30/24 | 55.03 on 03/13/24 | 998.33 on 02/28/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 10,314,552 | 149,321,728 | 103,424,960 | 88,584,272 | 102,913,952 |
| Shares Outstanding, K | 57,370 | 536,376 | 258,459 | 2,027,100 | 109,762 |
| Annual Sales | 22,170,000 | 28,190,000,000 | 9,869,200,000 | 45,006,000,000 | 13,117,200,000 |
| Annual Net Income | -267,070,000 | 6,717,000,000 | 3,619,600,000 | 8,025,000,000 | 3,953,600,000 |
| Last Quarter Sales | 10,050,000 | 8,196,000,000 | 2,517,700,000 | 11,865,000,000 | 3,434,300,000 |
| Last Quarter Net Income | -109,820,000 | 767,000,000 | 968,800,000 | -11,911,000,000 | 1,159,600,000 |
| 60-Month Beta | 2.68 | 0.60 | 0.39 | 0.45 | 0.17 |
| Per-Share Information | |||||
| Most Recent Earnings | -1.50 on 08/08/17 | 3.96 on 05/02/24 | 4.20 on 02/05/24 | -4.40 on 04/25/24 | 9.55 on 05/02/24 |
| Latest Earnings Date | 11/08/17 | 05/02/24 | 05/06/24 | 04/25/24 | 05/02/24 |
| Most Recent Dividend | N/A | 2.250 on 02/15/24 | N/A | 0.600 on 04/04/24 | N/A |
| Next Ex-Dividends Date | N/A | 05/16/24 | N/A | 04/04/24 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 14.87 | 29.92 | 42.10 | 24.04 |